Biocat

Not even the coronavirus has been able to crush the upward trend of a sector that has now crushed the €100-million barrier for five consecutive years. Since 2016, this figure has risen steadily, up nearly 3% on average each year. But what will the ecosystem’s potential be for attracting investment in 2025?

E-Pitch Training Program is aimed at projects and startups that need to improve their virtual presentation to investors, corporate ventures and scouts in the life sciences and health sector, both in substance (content) and form (the presentation).

Current generations will remember 2020 as the year everything changed by the whims of a virus that popped up almost overnight. The BioRegion wasn’t spared this abnormality, but as the healthcare and life sciences sector is strategic and essential to managing the pandemic, the revolution, in this case, brought out the best of the sector to fight the virus.

Jobs Listing

The sector’s top place for job offers in Catalonia. 

BioRegion Directory

More than 1,000 companies and a wide network of universities, hospitals and research entities.

News

30.09.2020
Aortyx, a spinoff of IQS that specializes in creating endovascular devices for aortic dissections, won the first annual Àlex Casta Awards for the best pitch in the BioRegion. The company’s CEO Jordi Martorell accepted...
29.09.2020
Life sciences and healthcare startups are kicking off the new school year in the best possible way: the 2020 BioRegion Report – Challenges ahead, presented by Biocat and CataloniaBio & HealthTech, shows that...
28.09.2020
With 3 months until the end of 2020, the life sciences and healthcare sector in Catalonia is flexing its muscles, in spite of expectations it would be a challenging year due to the Covid-19 pandemic. In just 9 months,...

Upcoming events

22.10.2020
Lloc:

DIGITAL FORMAT 

25.10.2020
Lloc:

Munich · Germany

START-UP GENERATION
30.05.2020

Judit Cubedo has a PhD in Cell and Molecular Biology from the UB and an MBA, plus 15 years of experience as a researcher working on studies to identify new biomarkers for cardiovascular disease and develop new diagnostic methods. She has published 35 scientific papers, is the co-inventor on 4 patents and has received numerous awards. One of them was from the MIT Technology Review for the invention that led to the company GlyCardial Diagnostics in 2017, where she is now CEO.